MIRXES-B (02629.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec7

MIRXES-B and XtalPi Collaborate to Build AI-Enabled Diagnostics and Treatment Integration Platform

11:03

Nov7

FOSUN Securities Recommends MIRXES-B with Strong Growth Prospects

02:47

Oct8

Mirxes Holding Co. Ltd. Obtains NMPA Approval for GASTROClear™ Device as a Class III Medical Device

22:18

Oct6

MIRXES-B and Xeraya Form Joint Venture for Cancer Detection

08:41

Aug25

MIRXES-B released FY2024 Semi-Annual earnings on August 25 (BJT), actual revenue HKD 74.79 M, actual EPS HKD -2.8942

15:00

MIRXES-B released FY2024 Q1 earnings on August 25 (BJT), actual revenue HKD 37.43 M, actual EPS HKD -1.4486

15:00

Schedules & Filings

Schedules

Filings

Aug25

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 41.1 M, Net Income -111.28 M, EPS -0.7269

May23

IPO(CST)

Listing Price HKD 23.3

May15

Earning Release(CST)

FY2024 Annual Earning Release (HKD) Revenue 158.07 M, Net Income -719.54 M, EPS -5.993

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change